20-Jan-2023 | Facts and Factors
According to Facts and Factors, the global progesterone market size was worth around USD 1027 million in 2021 and is predicted to grow to around USD 2136 million by 2030 with a compound annual growth rate (CAGR) of roughly 13 % between 2022 and 2030.
.png)
Progesterone is a bodily hormone that is mainly produced in the ovaries of the female population of humans and other species. It can also be produced in laboratories and clinical research facilities. The hormone is useful in managing pregnancy and other female reproductive concerns. The level of progesterone in the body can severely impact the menstrual period cycle as well as symptoms associated with menopause.
Browse the full “Progesterone Market Size, Share, Growth Analysis Report By Application (Dysfunctional Uterine Bleeding, Regulation Of The Menstrual Cycle, Contraception, Hyperplastic Precursor Lesions, and Endometrial Cancer), By Type (Synthetic and Natural), By Mode of Delivery (Oral, Injectable, and Suspended Form), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2030" report at https://www.fnfresearch.com/progesterone-market
All products that have progesterone in varying quantities are created in laboratories under strict supervision and are made available in the live market only after receiving necessary approvals from regulatory bodies. In the market, progesterone that is sold under the name of ‘natural progesterone’ is essentially made in the lab with the help of a chemical called diosgenin which originates from soy or wild yam.
Progesterone supplements are used to treat fertility-related problems along with medical issues surrounding menopausal symptoms. Non-prescription drugs containing progesterone may contain less or more quantity of the steroid than the amount indicated on the packaging and these products do not require approval from the Food and Drugs Administration authorities. However, progesterone drugs are recommended to be taken under medical supervision only as these are hormonal drugs and can lead to severe consequences if consumed in excessive quantities.
The global progesterone market is projected to grow owing to the increase in the number of reported infertility problems across the globe. Changing consumer lifestyles, additional stress, and poor eating habits are some of the external reasons why many women suffer from hormonal imbalances. Some of these conditions are not regulated by lifestyle choices but may be genetic as well. There are cases of structural problems in the reproductive system, failure to ovulate, implantation failure, and problems in the menstrual cycle are some of the other reasons why women face infertility. It is one of the most common medical issues observed worldwide.
Around 10% of the women population is known to suffer from some form of infertility. Progesterone is a leading drug used in the treatment of medical issues. It is considered an important part of the entire treatment process as it helps in implantation and during pregnancy. Medical professionals have different preferences when it comes to the type of medicine chosen for using progesterone treatment depending on their prior experiences with the methods.
One of the major growth restraining factors is the impact of medicines on the mental health of patients. Infertility, problems of the menstrual cycle, and reproduction-related concerns, in general, are very sensitive topics and it takes a toll on the mental and physical health of the patient. In some cases, the use of progesterone drugs is known to have side effects like weight fluctuation, acne problems, hair loss, and others. These issues give rise to more discomfort among the patient undergoing the treatment directly impacting mental health.
The increasing research & development activities may provide growth opportunities while the lack of awareness may act as a major challenge during the forecast period
.png)
Segmental Overview
The global progesterone market is segmented based on application, type, mode of delivery, and region
Based on type, the global market segments are synthetic and natural. In 2021, the global market witnessed the highest growth in the synthetic segment. The expansion was driven by the higher production number of synthetic drugs compared to the natural form. Most medical professionals prescribe safe clinically-manufactured drugs to treat hormonal imbalance and pregnancy-related issues because the medicines are altered to leave a maximum impact. However, there is a large segment of the population that prefers natural drugs over synthetic ones. For instance, around 80% of the world population currently relies on traditional medicines, as per the World Health Organization.
Based on mode of delivery, the global market divisions are oral, injectable, and suspended form. The oral segment led the global market expansion in 2021, followed by the injectable form. Most progesterone-related drugs taken by women are available in oral form as there is less discomfort however some medications can also be administered using injections or through the women's sex organ. Progesterone treatment amongst pregnant women helps prevent premature birth and is recommended to start before or up to 24 months of pregnancy.
Regional Overview
North America is projected to lead the global progesterone market owing to the growing awareness rate amongst the population about progesterone-related medical treatment processes. This can be attributed to the initiatives undertaken by government agencies to educate the population about the right form of medication and its advantages. This has resulted in the spread of correct information in these countries.
The regional growth may also be driven by the growing number of players investing in the progesterone drug development processes. Growth in Asia-Pacific may be driven by the growing pharmaceutical medicine and the large-scale adoption of generic medicines in some nations. Generic medicines are as effective as branded medicines while also being less expensive which means more people can have access to the drugs.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 1027 Million |
Projected Market Size in 2030 |
USD 2136 million |
CAGR Growth Rate |
13% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2030 |
Key Market Players |
Cadila Pharmaceuticals, ALKEM Labs, Cipla Ltd, Teva Pharmaceuticals, BioNPharma, and others. |
Key Segment |
By Application, Type, Mode of Delivery, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East &, Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Competitive Analysis
The global progesterone market is led by players like Cadila Pharmaceuticals, ALKEM Labs, Cipla Ltd, Teva Pharmaceuticals, and BioNPharma to name a few.
Recent Developments:
- In October 2022, Sun Pharma received approval from the Central Drug Standard Control Organization to manufacture and advertise Progesterone Sustained-Release Tablets
- In September 2021, Theramex announced the launch of Bijuva® / Bijuve® across the UK and Europe
The global progesterone market is segmented as follows:
By Application
- Dysfunctional Uterine Bleeding
- Regulation Of The Menstrual Cycle
- Contraception
- Hyperplastic Precursor Lesions
- Endometrial Cancer
By Type
By Mode of Delivery
- Oral
- Injectable
- Suspended Form
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1 (347) 690-0211
Email: [email protected]
Web: https://www.fnfresearch.com
